Table 2

Clinical and investigative features at presentation

PHVASurgical shuntingSignificance
(n=21)(n=15)(p value)
Age1 31 (16–65)36 (20–57)NS2
Duration of history, months1 3 (0–84)3 (0–204)NS2
Clinical features4
 Ascites1815NS3
 Variceal haemorrhage43NS3
 Hepatic encephalopathy5 58NS3
 Muscle wasting6 76NS3
Radiological features4
 Short length hepatic vein stenosis214
 IVC occlusion32
Laboratory findings1, 7
 Serum bilirubin (μM/l)31 (6–179)60 (20–255) p<0.012
 Serum AST (U/l)48 (12–2410)69 (23–504)NS2
 Serum albumin (g/l)34 (20–45)32 (26–39)NS2
 Serum creatinine (μM/l)8 87 (47–247)104 (61–522)
 Prothrombin INR1.4 (1.0–2.9)1.4 (1.2–3.2)NS2
Histological features1, 9
 Centrilobular necrosis score1 (1–3)2 (0–3)p<0.052
 Fibrosis score2 (0–3)1 (0–3)NS2
  • 1Median values (range given in brackets).

  • 2Mann-Whitney U test; 3Fisher’s exact test. p values ⩾0.05 are denoted as not significant (NS).

  • 4Absolute numbers.

  • 5Clinical grade 1 or higher.

  • 6Defined where clinically obvious.

  • 7Normal laboratory values: bilirubin, 1–22 μM/l; AST, 5–43 U/l; albumin, 34–51 g/l; creatinine, 60–100 μM/l.

  • 8Two patients in shunt group treated with haemodialysis prior to surgery.

  • 9Centrilobular necrosis and fibrosis scores: 0=none; 1=mild; 2=moderate; 3=severe.

  • AST, aspartate aminotransferase.